Refine Search
(52)
(168)
(376)
(527)

Depression - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Depression - Pipeline Review, H1 2019’, provides an overview of the Depression pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Depression, complete wit...

Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H1 2019’, provides an overview of the Influenza A Virus, H1N1 Subtype Infections pipeline landscape.

The report provides comprehensive information on...

Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H1 2019’, provides an overview of the Influenza A Virus, H5N1 Subtype Infections pipeline landscape.

The report provides comprehensive information on...

Mild Cognitive Impairment - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Mild Cognitive Impairment - Pipeline Review, H1 2019’, provides an overview of the Mild Cognitive Impairment pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Bone Marrow Transplant Rejection - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bone Marrow Transplant Rejection - Pipeline Review, H1 2019’, provides an overview of the Bone Marrow Transplant Rejection pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Grass Pollen Allergy - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Grass Pollen Allergy - Pipeline Review, H1 2019’, provides an overview of the Grass Pollen Allergy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gras...

Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H1 2019’, provides an overview of the Granulomatosis with Polyangiitis (Wegener Polyangiitis) pipeline landscape.

The report provides co...

Primary Hyperoxaluria - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Primary Hyperoxaluria - Pipeline Review, H1 2019’, provides an overview of the Primary Hyperoxaluria pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pr...

Dyslipidemia - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Dyslipidemia - Pipeline Review, H1 2019’, provides an overview of the Dyslipidemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Dyslipidemia, comple...

Arterial Thrombosis - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Arterial Thrombosis - Pipeline Review, H1 2019’, provides an overview of the Arterial Thrombosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Arteri...

Diabetic Nephropathy - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Nephropathy - Pipeline Review, H1 2019’, provides an overview of the Diabetic Nephropathy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Diab...

Contrast Induced Nephropathy - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Contrast Induced Nephropathy - Pipeline Review, H1 2019’, provides an overview of the Contrast Induced Nephropathy pipeline landscape.

The report provides comprehensive information on the therapeutics under deve...

Arrhythmias - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Arrhythmias - Pipeline Review, H1 2019’, provides an overview of the Arrhythmias pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Arrhythmias, complete ...

Epilepsy - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H1 2019’, provides an overview of the Epilepsy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Epilepsy, complete with anal...

Alzheimer's Disease - Pipeline Review, H1 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2019’, provides an overview of the Alzheimer's Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2019’, provides an overview of the Congestive Heart Failure (Heart Failure) pipeline landscape.

The report provides comprehensive information on the...

Nicotine Addiction - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Nicotine Addiction - Pipeline Review, H1 2019’, provides an overview of the Nicotine Addiction pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Nicotine...

Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2019’, provides an overview of the Deep Vein Thrombosis (DVT) pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2019’, provides an overview of the Attention Deficit Hyperactivity Disorder (ADHD) pipeline landscape.

The report provides comprehensive info...

Pulmonary Embolism - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pulmonary Embolism - Pipeline Review, H1 2019’, provides an overview of the Pulmonary Embolism pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pulmonar...

Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2019’, provides an overview of the Chemotherapy Induced Nausea and Vomiting pipeline landscape.

The report provides comprehensive information on the...

Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2019’, provides an overview of the Spinal Muscular Atrophy (SMA) pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Osteoarthritis - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H1 2019’, provides an overview of the Osteoarthritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Osteoarthritis, ...

Polycythemia Vera - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Polycythemia Vera - Pipeline Review, H1 2019’, provides an overview of the Polycythemia Vera pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Polycythem...

Fibrosarcoma - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fibrosarcoma - Pipeline Review, H1 2019’, provides an overview of the Fibrosarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fibrosarcoma, comple...

Crohn's Disease (Regional Enteritis) - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Crohn's Disease (Regional Enteritis) - Pipeline Review, H1 2019’, provides an overview of the Crohn's Disease (Regional Enteritis) pipeline landscape.

The report provides comprehensive information on the...

Osteosarcoma - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Osteosarcoma - Pipeline Review, H1 2019’, provides an overview of the Osteosarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Osteosarcoma, comple...

Nasopharyngeal Cancer - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Nasopharyngeal Cancer - Pipeline Review, H1 2019’, provides an overview of the Nasopharyngeal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Na...

Diabetic Macular Edema - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Macular Edema - Pipeline Review, H1 2019’, provides an overview of the Diabetic Macular Edema pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Sepsis - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Sepsis - Pipeline Review, H1 2019’, provides an overview of the Sepsis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Sepsis, complete with analysis b...

Community Acquired Pneumonia - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Community Acquired Pneumonia - Pipeline Review, H1 2019’, provides an overview of the Community Acquired Pneumonia pipeline landscape.

The report provides comprehensive information on the therapeutics under deve...

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2019’, provides an overview of the Systemic Sclerosis (Scleroderma) pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Diabetic Peripheral Neuropathy - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Peripheral Neuropathy - Pipeline Review, H1 2019’, provides an overview of the Diabetic Peripheral Neuropathy pipeline landscape.

The report provides comprehensive information on the therapeutics under ...

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2019’, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) pipeline landscape.

The report provides comprehensive info...

Premature Labor (Tocolysis) - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Premature Labor (Tocolysis) - Pipeline Review, H1 2019’, provides an overview of the Premature Labor (Tocolysis) pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Bronchopulmonary Dysplasia - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bronchopulmonary Dysplasia - Pipeline Review, H1 2019’, provides an overview of the Bronchopulmonary Dysplasia pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Pruritus - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pruritus - Pipeline Review, H1 2019’, provides an overview of the Pruritus pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pruritus, complete with anal...

Synovial Sarcoma - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Synovial Sarcoma - Pipeline Review, H1 2019’, provides an overview of the Synovial Sarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Synovial Sar...

Oral Mucositis - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Oral Mucositis - Pipeline Review, H1 2019’, provides an overview of the Oral Mucositis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Oral Mucositis, ...

Hypoglycemia - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hypoglycemia - Pipeline Review, H1 2019’, provides an overview of the Hypoglycemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hypoglycemia, comple...

Optic Neuropathy - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Optic Neuropathy - Pipeline Review, H1 2019’, provides an overview of the Optic Neuropathy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Optic Neurop...

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2019’, provides an overview of the Non Alcoholic Fatty Liver Disease (NAFLD) pipeline landscape.

The report provides comprehensive information on t...

Down Syndrome - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Down Syndrome - Pipeline Review, H1 2019’, provides an overview of the Down Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Down Syndrome, com...

Viral Conjunctivitis - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Viral Conjunctivitis - Pipeline Review, H1 2019’, provides an overview of the Viral Conjunctivitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Vira...

Blepharitis - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Blepharitis - Pipeline Review, H1 2019’, provides an overview of the Blepharitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Blepharitis, complete ...

Atrial Fibrillation - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Atrial Fibrillation - Pipeline Review, H1 2019’, provides an overview of the Atrial Fibrillation pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Atrial...

Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2019’, provides an overview of the Coronary Artery Disease (CAD) (Ischemic Heart Disease) pipeline landscape.

The report provides comp...

Drug Addiction - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Drug Addiction - Pipeline Review, H1 2019’, provides an overview of the Drug Addiction pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Drug Addiction, ...

Autism - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Autism - Pipeline Review, H1 2019’, provides an overview of the Autism pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Autism, complete with analysis b...

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H1 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H1 2019’, provides an overview of the Non-Alcoholic Steatohepatitis (NASH) pipeline landscape.

The report provides comprehensive information on the therape...

Traumatic Brain Injury - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Traumatic Brain Injury - Pipeline Review, H1 2019’, provides an overview of the Traumatic Brain Injury pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Post-Operative Pain - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Post-Operative Pain - Pipeline Review, H1 2019’, provides an overview of the Post-Operative Pain pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Post-O...

Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2019’, provides an overview of the Alpha- Antitrypsin Deficiency pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Chemotherapy Induced Anemia - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chemotherapy Induced Anemia - Pipeline Review, H1 2019’, provides an overview of the Chemotherapy Induced Anemia pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Osteogenesis Imperfecta - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Osteogenesis Imperfecta - Pipeline Review, H1 2019’, provides an overview of the Osteogenesis Imperfecta pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2019’, provides an overview of the Chemotherapy Induced Peripheral Neuropathy pipeline landscape.

The report provides comprehensive information on...

Duchenne Muscular Dystrophy - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Duchenne Muscular Dystrophy - Pipeline Review, H1 2019’, provides an overview of the Duchenne Muscular Dystrophy pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Fabry Disease - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fabry Disease - Pipeline Review, H1 2019’, provides an overview of the Fabry Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fabry Disease, com...

Familial Adenomatous Polyposis - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Familial Adenomatous Polyposis - Pipeline Review, H1 2019’, provides an overview of the Familial Adenomatous Polyposis pipeline landscape.

The report provides comprehensive information on the therapeutics under ...

Primary Immune Deficiency (PID) - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Primary Immune Deficiency (PID) - Pipeline Review, H1 2019’, provides an overview of the Primary Immune Deficiency (PID) pipeline landscape.

The report provides comprehensive information on the therapeutics unde...

Burns - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Burns - Pipeline Review, H1 2019’, provides an overview of the Burns pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Burns, complete with analysis by s...

Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2019’, provides an overview of the Juvenile Macular Degeneration (Stargardt Disease) pipeline landscape.

The report provides comprehensive ...

Meniere Disease - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Meniere Disease - Pipeline Review, H1 2019’, provides an overview of the Meniere Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Meniere Diseas...

Ragweed Pollen Allergy - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ragweed Pollen Allergy - Pipeline Review, H1 2019’, provides an overview of the Ragweed Pollen Allergy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Periodontitis - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Periodontitis - Pipeline Review, H1 2019’, provides an overview of the Periodontitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Periodontitis, com...

Ocular Hypertension - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ocular Hypertension - Pipeline Review, H1 2019’, provides an overview of the Ocular Hypertension pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ocular...

Scar - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Scar - Pipeline Review, H1 2019’, provides an overview of the Scar pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Scar, complete with analysis by stag...

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2019’, provides an overview of the Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) pipeline landscape.

The report provides comprehensive information on...

Becker Muscular Dystrophy - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Becker Muscular Dystrophy - Pipeline Review, H1 2019’, provides an overview of the Becker Muscular Dystrophy pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Crigler-Najjar Syndrome - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Crigler-Najjar Syndrome - Pipeline Review, H1 2019’, provides an overview of the Crigler-Najjar Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal Cell Carcinoma Syndrome) - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gorlin Syndrome (Basal Cell Nevus Syndrome) - Pipeline Review, H1 2019’, provides an overview of the Gorlin Syndrome (Basal Cell Nevus Syndrome) pipeline landscape.

The report provides comprehensive information ...

Nasal Polyps (Nasal Polyposis) - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Nasal Polyps - Pipeline Review, H1 2019’, provides an overview of the Nasal Polyps pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Nasal Polyps, comple...

Polycystic Ovarian Syndrome - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Polycystic Ovarian Syndrome - Pipeline Review, H1 2019’, provides an overview of the Polycystic Ovarian Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Rectal Cancer - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rectal Cancer - Pipeline Review, H1 2019’, provides an overview of the Rectal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rectal Cancer, com...

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2019’, provides an overview of the B-Cell Chronic Lymphocytic Leukemia pipeline landscape.

The report provides comprehensive information on the therapeut...